Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Olanzapine in Schizophrenic Patients with EPS
NCT00331825Phase 4Completed
- Start
- Jul 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in schizophrenia comparing Risperidone with Olanzapine (2 arms). Primary endpoint: Percentage of using concomitant anticholinergic drugs at 8 weeks. Started Jul 2000; status: completed.
02
Drugs
risperidoneolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00331825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331825.